fda update tirzepatide Big in pediatric diabetes care 🩺 Mounjaro® (tirzepatide) is now FDA-approved for children ≥10 years old with Type 2 diabetes as an adjunct to diet and exercise. What this means ⬇️ FDA approval for Zepbound (tirzepatide)

Managing Side Effects While many individuals tolerate semaglutide well, some may experience side effects, including: Nausea Vomiting Diarrhea Constipation Abdominal pain These symptoms often improve over time and may be managed with dietary adjustments

To ensure compliance before prescribing, follow this checklist: Confirm the pharmacys 503A license with the state board of pharmacy

If you are starting a medical weight loss program, your cannabis regimen may need an adjustment to ensure it supports your new lifestyle

Liver Strain Similarly, rare cases of liver injury have been reported in semaglutide users

Weighing the Risks: While Ozempic is safe for most people, its not without risks